Insilico Medicine
Xiao Ding has extensive work experience in the pharmaceutical industry. They currently hold the position of Senior Director and Head of Chemistry at Insilico Medicine since May 2021. Prior to this, they worked at Luo Shi Pharmaceutical from November 2020 to April 2021, where they served as the Scientific Lead in the Roche Accelerator program and as a Senior Scientist. Before that, Xiao Ding was employed at GSK, where they worked as a Scientist in the ND DPU, R&D China division from October 2012 to October 2017. They also had an internship at GSK from April 2011 to April 2012, where they worked as an Intern in the AB DPU at the UP site.
Xiao Ding pursued their education in the field of chemistry with a focus on medicinal and organic chemistry. Xiao completed their Bachelor's degree in Organic Chemistry from Anhui University, where they studied from 2002 to 2006. After that, they furthered their studies at Shanghai Institute of Materia Medica, where they obtained a PhD in Medicinal Chemistry, graduating in 2011.
This person is not in any offices
Insilico Medicine
2 followers
Insilico Medicine is an artificial intelligence company headquartered in Hong Kong, with R&D and management resources in the USA, Belgium, Russia, UK, Taiwan, and China sourced through hackathons and competitions. The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through excellence in biomarker discovery, drug development, digital medicine, and aging research.